Promotie Pragya Pathak: LRRK2-directed therapeutics in Parkinson's disease: from molecular tools to functional insights

  • Pragya Pathak

Pers / media: Expert CommentPopular

Description

Op dinsdag 10 juni 2025 verdedigt Pragya Pathak het proefschrift 'LRRK2-directed therapeutics in Parkinson's disease: from molecular tools to functional insights' aan de Rijksuniversiteit Groningen.

Periode18-mrt.-2025

Media-aandacht

1

Media-aandacht